SARTORIUS AG Sartorius AG Share Price Deutsche Boerse AG
Equities
SRT
DE0007165607
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 220 EUR | -0.23% |
|
+1.85% | -16.67% |
| 04-30 | SARTORIUS : Target cut by -6.1% |  |
| 04-24 | SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg | ZD |
| Sales 2024 * | 3.58B 3.85B 307B | Sales 2025 * | 4.02B 4.33B 345B | Capitalization | 17.53B 18.86B 1,504B |
|---|---|---|---|---|---|
| Net income 2024 * | 214M 230M 18.37B | Net income 2025 * | 343M 369M 29.44B | EV / Sales 2024 * | 6.03 x |
| Net Debt 2024 * | 4.05B 4.36B 348B | Net Debt 2025 * | 3.82B 4.11B 328B | EV / Sales 2025 * | 5.31 x |
| P/E ratio 2024 * |
77.4
x | P/E ratio 2025 * |
52.2
x | Employees | 14,614 |
| Yield 2024 * |
0.3% | Yield 2025 * |
0.4% | Free-Float | 35.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sartorius AG
More press releases
| 1 day | -0.23% | ||
| 1 week | +1.85% | ||
| Current month | -2.22% | ||
| 1 month | -16.51% | ||
| 3 months | -20.43% | ||
| 6 months | +3.77% | ||
| Current year | -16.67% |
1 week
218.00
228.00
1 month
205.00271.50
Current year
205.00290.50
1 year
182.60310.00
3 years
182.60839.00
5 years
140.00839.00
10 years
21.61839.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 30/04/99 | |
| Chief Tech/Sci/R&D Officer | 59 | 31/12/94 | |
Volker Niebel
COO | Chief Operating Officer | 67 | 31/12/00 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
BRD | Director/Board Member | 69 | 31/12/19 |
| Director/Board Member | 75 | 28/11/11 | |
| Director/Board Member | 58 | 05/04/17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/05/24 | 220 | -0.23% | 0 |
| 02/05/24 | 220.5 | -2.00% | 8 |
| 30/04/24 | 225 | -0.66% | 118 |
| 29/04/24 | 226.5 | +4.86% | 10 |
| 26/04/24 | 216 | -4.00% | 0 |
Delayed Quote Deutsche Boerse AG, May 03, 2024 at 07:00 am
More quotes
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
16/05/2024
- Capital Markets Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
284.3
EUR
Average target price
330.8
EUR
Spread / Average Target
+16.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -42.33% | 2.82B | |
| +17.00% | 1.85B | |
| -0.51% | 1.66B | |
| +27.15% | 1.23B | |
| -13.90% | 989M | |
| -21.76% | 896M | |
| -2.72% | 734M | |
| -23.95% | 667M | |
| +6.84% | 498M |
- Stock Market
- Equities
- SRT3 Stock
- SRT Stock
